Patents by Inventor Steven Pollard

Steven Pollard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • FUNCTIONAL NUCLEIC ACID MOLECULE AND METHOD
    Publication number: 20260241035
    Abstract: Disclosed are constructs configured to express adverse (for example cytotoxic and immunomodulatory) payloads in cells, which constructs may be used to treat or prevent recurrent/secondary cancer/tumours and to prime, induce, raise or promote an immune response which is effective against a recurrent/secondary cancer/tumour which might arise from said primary cancer/tumour.
    Type: Application
    Filed: July 28, 2023
    Publication date: August 20, 2026
    Applicant: THE UNIVERSITY COURT OF THE UNIVERSITY OF EDINBURGH
    Inventors: Steven Pollard, Mantas Matjusaitis
  • FUNCTIONAL NUCLEIC ACID MOLECULE AND METHOD
    Publication number: 20240092847
    Abstract: The disclosure relates to synthetic super-enhancers activated by one or more transcription factors. In particular, the present disclosure describes synthetic super-enhancers that are activated by one or more transcription factors expressed in a target cell and used to express transgenes, such as adverse payloads, upon activation of the synthetic super-enhancer by the transcription factor(s).
    Type: Application
    Filed: January 26, 2022
    Publication date: March 21, 2024
    Inventors: Steven Pollard, Ute Koeber, Mantas Matjusaitis
  • Neural stem cells
    Publication number: 20060014281
    Abstract: A homogenous, symmetrically dividing population of adherent neural stem cells is obtained from ES cells or foetal or adult brain isolates, using an activator of a signalling pathway downstream of a receptor of the EGF receptor family, optionally in combination with an activator of a signalling pathway downstream of an FGF receptor. The neural stem cell population is highly pure and retains the ability to differentiate into neurons after in excess of 100 passages.
    Type: Application
    Filed: June 9, 2005
    Publication date: January 19, 2006
    Inventors: Luciano Conti, Steven Pollard, Austin Smith